Executive Compensation-Related Fees
| | | | | | | | | | | |
| Fiscal Year Ended December 31, 2021 | Fiscal Year Ended December 31, 2020 |
| | |
Executive Compensation-Related Fees(1) | C$101,237.79 | C$0 |
All Other Fees | C$0 | C$0 |
Total Fees Paid | C$101,237.79 | C$0 |
| | | |
(1) See discussion above for further details regarding the services rendered. |
Market Positioning and Benchmarking
As part of the executive compensation review and design process, the Human Resources and Compensation Committee established a peer group for Fiscal 2021 (the "Comparator Group") to benchmark compensation.
The selection criteria used to determine the composition of the Comparator Group include the following:
•companies competing for similar talent in North America;
•companies in similar industry sectors;
•publicly-traded organizations in Canada and the United States; and
•companies of comparable size, measured by market capitalization.
The companies forming the Comparator Group for Fiscal 2021 meet all or some of the foregoing criteria and are listed below:
| | | | | |
Comparator Group |
BRP Inc. | Blue Bird Corporation |
NFI Group Inc. | XL Fleet Corp. |
CAE Inc. | Canoo Inc. |
Héroux-Devtek Inc. | Workhorse Group Inc. |
Savaria Corporation | Nikola Corporation |
GreenPower Motor Company Inc. | Hyliion Holdings Corp. |
PACCAR Inc | Lordstown Motors Corp. |
Navistar International Corporation | Proterra Inc. |
This Comparator Group, supplemented by other sources of competitive pay information, is an important input in establishing compensation levels and structure for Fiscal 2021 and beyond. The Human Resources and Compensation Committee, in accordance with its compensation philosophy, will
37
periodically assess the competitiveness of the compensation package to make compensation-related decisions.
Principal Elements of Compensation
The compensation of the Company’s executive officers includes three major elements: (i) base salary; (ii) short-term incentives, consisting of annual bonuses and (iii) long-term equity incentives, consisting of awards under the Omnibus Plan. Perquisites and personal benefits are not a significant element of compensation of the executive officers of the Company. The Company’s compensation philosophy is to set the total direct compensation package for its Named Executive Officers at market median based on the Company's Comparator Group and is designed to result in above market median compensation when performance so warrants.
Base Salary
Annual base salaries are intended to provide a fixed component of compensation to Lion’s Named Executive Officers, reflecting their skill sets, experience, roles and responsibilities. Base salaries for Lion’s Named Executive Officers have generally been set at levels deemed necessary to attract and retain individuals with superior talent. A Named Executive Officer’s base salary is determined by taking into consideration the NEO’s total compensation package and the Company’s overall compensation philosophy.
The Human Resources and Compensation Committee reviews base salaries periodically, and at least annually, to ensure that they continue to reflect individual performance and market conditions, and merit increases or other adjustments are made, as deemed appropriate. Additionally, Lion may choose to adjust base salaries as warranted throughout the year to reflect promotions or other changes in the scope or breadth of a Named Executive Officer’s role or responsibilities, as well as to maintain market competitiveness, including within the Comparator Group.
Annual Short-Term Incentive Program (STIP)
In accordance with the terms of their respective employment agreements, certain of Lion’s Named Executive Officers and other executive officers are eligible to receive discretionary annual cash bonuses based on individual and company performance or otherwise as may be determined by Lion’s Board of Directors from time to time. The Company's STIP is designed to motivate executive officers to meet the Company's business and financial objectives generally.
For Fiscal 2021, the Human Resources and Compensation Committee adopted an approach to setting the annual cash bonuses awarded to NEOs under the STIP pursuant to which 50% of the total amount of annual bonus awarded to NEOs was based on the Company's performance, and 50% on individual performance. This methodology is intended to be used by the Committee in setting STIP awards for all NEOs in the future.
For Fiscal 2022 and beyond, with respect to NEOs, the bonus to be awarded under the STIP will be determined at the end of each fiscal year by the Board of Directors upon recommendation from the Human Resources and Compensation Committee. For Fiscal 2022, the Board of Directors determined that STIP for NEOs and other members of management will be based on business performance metrics (50%) and achievement of personal goals (50%). Business performance metrics and targets and corresponding payout levels are established by the Board of Directors upon recommendation from the Human Resources and Compensation Committee.
The following performance metrics comprise the business performance component of the Fiscal 2022 STIP:
| | | | | |
Performance Metric | Weight of Metric |
Revenue | 50% |
Gross Margin | 25% |
Adjusted EBITDA(1) | 25% |
38
(1) Refer to the management discussion and analysis of the Company for the year ended December 31, 2021 for additional information on Adjusted EBITDA, a non-IFRS measure.
The individual performance of the NEO is determined by clear pre-determined criteria for achievement of the respective NEO’s personal goals.
In accordance with the terms and provisions of the STIP, the actual STIP awards can range from zero to two times the NEOs’ target STIP, the actual award dependent upon achievement of the previously described business and individual performance goals. Furthermore, if a NEO doesn’t meet a certain threshold on his/her personal goals, his/her actual STIP award will be nil for that reference year, regardless of the business performance.
Long-Term Equity Incentives
Equity-based incentive awards granted to Named Executive Officers are variable elements of compensation which are designed to align Lion’s interests and those of its shareholders with those of its employees, including its Named Executive Officers. Equity awards reward performance and continued employment by an executive officer, with associated benefits to Lion of attracting and retaining employees. The Company believes that options, restricted share units ("RSUs") and performance share units ("PSUs") provide executive officers with a strong link to long-term corporate performance and the creation of shareholder value. As of the date hereof, stock option awards and RSUs are the two types of equity awards that Lion has granted to its Named Executive Officers. See "Long-Term Incentive Plans" below for vesting, settlement, and other terms of such awards.
Prior to adoption of the Omnibus Plan, Lion made equity-based awards to NEOs by issuing options under the Company’s legacy equity-based incentive plan adopted in November 2017, as amended and restated in December 2019 and May 2021 (the "Legacy Plan"). Following adoption of the Omnibus Plan, equity-based awards made by Lion have been made under the Omnibus Plan, and no further grants were nor will be made under the Legacy Plan. The terms of Lion’s equity plans are described below in the section entitled "Executive Compensation – Principal Elements of Compensation – Long-Term Incentive Plans (LTIP)".
In connection with the grants of equity-based awards, the Human Resources and Compensation Committee determines the grant size and terms to be recommended to the Board of Directors. As part of their annual review of the Company’s compensation practices, the Human Resources and Compensation Committee and the Board of Directors determine the precise structure of long-term incentive compensation. For Fiscal 2021, none of the NEOs received long-term incentive compensation grants pursuant to annual LTIP awards. Mr. Duquette and Ms. Giroux received a one-time special LTIP grant upon hire, comprised of 50% RSUs and 50% stock options, and Mr. Piern received a one-time special LTIP grant upon hire, comprised of 9,409 RSUs and 236,569 stock options. Option-based awards granted under the Omnibus Plan in Fiscal 2021 have a 10-year term and vest in four equal tranches over the first four employment anniversary dates. RSU-based awards granted in Fiscal 2021 vest entirely on the third employment anniversary date and can be settled in cash or Common Shares at the option of the Company promptly following vesting.
For Fiscal 2022, the Board of Directors determined that LTIP for NEOs will be divided in two types of awards which are the Restricted Shares Units (RSUs) and Options, both weighted at 50%.
Long-Term Incentive Plans (LTIP)
The principal features of Lion’s Long-Term Incentive Plans (LTIP) are summarized below. As further discussed in the section "Executive Compensation ― Discussion and Analysis - Principal Elements of Compensation" above, the value of the LTIP grants varies by the level of responsibility and the Named Executive Officer’s performance as assessed by the Human Resources and Compensation Committee and the Board of Directors.
Omnibus Plan
General. Lion adopted its Omnibus Plan in May 2021 in connection with the listing of its Common Shares on the NYSE and the TSX. The Omnibus Plan provides different types of equity-based incentives to be granted to certain of the Company’s directors, executive officers, employees and consultants, including options, RSUs, PSUs and DSUs, collectively referred to as "awards". The Board of Directors is responsible for administering the Omnibus Plan and may delegate its responsibilities thereunder to a committee thereof or to a plan administrator. The following discussion is qualified in its entirety by the full text of the Omnibus Plan and each grant agreement evidencing the applicable awards.
39
The Board of Directors is entitled to, in its sole discretion, from time to time, designate the directors, executive officers, employees and consultants to whom awards will be granted and determine, if applicable, the number of Common Shares to be covered by such awards and the terms and conditions of such awards. Awards under the Omnibus Plan are generally made by the Board of Directors upon recommendation from the Human Resources and Compensation Committee.
For Fiscal 2022, Lion’s LTIP for NEOs is divided in two vehicles which are the Restricted Shares Units (RSUs) and Options, both weighted at 50%.
Shares Available Under the Plan. The maximum number of Common Shares available for issuance, in the aggregate, under the Omnibus Plan and the Legacy Plan shall not exceed ten percent (10%) of the aggregate number of Common Shares issued and outstanding from time to time (calculated on a non-diluted basis). As of December 31, 2021, 190,002,712 Common Shares were issued and outstanding and, as such, a maximum of 19,000,271 Common Shares could be issued in the aggregate pursuant to awards granted under the Omnibus Plan and the Legacy Plan.
The number of Common Shares available for issuance under the Omnibus Plan and the Legacy Plan will increase as the number of issued and outstanding Common Shares increases from time to time. Any Shares subject to an award which has been exercised or settled in Common Shares will again be available for issuance under the Omnibus Plan. Common Shares will not be deemed to have been issued pursuant to the Omnibus Plan with respect to any portion of an award that is settled in cash.
Subject to the insider participation limit set out below and the overall shares available under the Omnibus Plan described above, the Omnibus Plan does not limit the maximum number of Common Shares that any one person or company is entitled to receive under the Omnibus Plan.
Insider Participation Limit. The aggregate number of Common Shares issuable to insiders and their associates at any time under the Omnibus Plan, the Legacy Plan or any other proposed or established share compensation arrangement, will not exceed 10% of the issued and outstanding Common Shares, and the aggregate number of Common Shares issued to insiders and their associates under the Omnibus Plan or any other proposed or established share compensation arrangement within any one-year period will not exceed 10% of the issued and outstanding Common Shares.
Options. All options granted under the Omnibus Plan will have an exercise price determined and approved by the Board of Directors at the time of grant, which will not be less than the market price of the Common Shares on the date of the grant. For purposes of the Omnibus Plan, the market price of the Common Shares as of a given date will generally be the volume weighted average trading price on the TSX (on the NYSE for U.S. based employees) for the five trading days immediately preceding such date.
Subject to any vesting conditions set forth in a participant’s grant agreement, an option will be exercisable during a period established by the Board of Directors which will not be more than ten years from the grant of the option. The Omnibus Plan provides that the exercise period will automatically be extended if the date on which it is scheduled to terminate will fall during a blackout period. In such cases, the extended exercise period will terminate ten business days after the last day of the blackout period. The Board of Directors is entitled, in its discretion, to provide for procedures to allow a participant to elect to undertake a "cashless exercise" or a "net exercise" in respect of options.
Share Units. The Board of Directors is authorized to grant RSUs, PSUs and DSUs evidencing the right to receive Common Shares, cash based on the value of a Common Share or a combination thereof at some future time to eligible persons under the Omnibus Plan. Although DSUs may be available for grant to directors, executive officers, employees and consultants, Lion currently expects to only grant DSUs as a form of non-executive director compensation.
RSUs generally become vested, if at all, following a period of continuous employment. PSUs are similar to RSUs, but their vesting is, in whole or in part, conditioned on the attainment of specified performance metrics as may be determined by the Board of Directors. The terms and conditions of grants of RSUs and PSUs, including the quantity, type of award, grant date, vesting conditions, vesting periods, settlement date and other terms and conditions with respect to these awards will be set out in the participant’s grant agreement. Subject to the achievement of the applicable vesting conditions, the settlement of an RSU or PSU will generally occur on or as soon as reasonably practicable following the vesting date. The settlement of a DSU will generally occur following a pre-established deferral period, which may be upon or following the participant ceasing to be a director, executive officer, employee or consultant of Lion, subject to satisfaction of any applicable conditions.
40
RSUs, PSUs and DSUs can be settled, at Lion's option, in cash or Common Shares which shares can be bought on secondary markets or issued from treasury.
Dividend Share Units. If, as the case may be, dividends (other than share dividends) are paid on Common Shares, additional share unit equivalents may be automatically granted to each participant who holds RSUs, PSUs or DSUs on the record date for such dividends. If the Board of Directors provides for an award of RSUs, PSUs or DSUs to receive dividend share units, such units will be subject to the same vesting or other conditions applicable to the underlying RSUs, PSUs or DSUs, as applicable.
Recapitalization. In the event of any change in the capital structure or any other change affecting the Common Shares, the Board of Directors will equitably adjust the aggregate number or kind of shares that may be delivered under the Omnibus Plan, the number or kind of shares or other property (including cash) subject to an award, and the terms and conditions of awards.
In the event of any other change in the capital structure or business of Lion or other corporate transaction, the Board of Directors will be entitled, in its sole discretion, to make equitable adjustments to be made in such circumstances in order to maintain the economic rights of the participants in respect of awards under the Omnibus Plan.
Change of Control. In the event of a change of control, or other changes in Lion or the outstanding Common Shares by reason of a recapitalization, reorganization, arrangement, merger, consolidation, combination, exchange or other relevant change, the Board of Directors will have the power, in its sole discretion, to modify the terms of the Omnibus Plan and/or the awards granted thereunder, including to cause the power to accelerate vesting, waive any forfeiture conditions or otherwise modify or adjust any other condition or limitation regarding an award. The Board of Directors will be entitled, at its discretion, to accelerate the time of exercisability of an award, redeem in whole or in part outstanding awards, cancel awards that remain subject to a restricted period, and make such adjustments to awards then outstanding as the Board of Directors deems appropriate to reflect the change of control or other such event, including providing for the substitution, assumption, or continuation of awards by the successor company or a parent or subsidiary thereof.
Trigger Events. The Omnibus Plan provides that, except as otherwise determined by the Board of Directors, upon the termination for cause of a participant, any awards granted to such participant, whether vested or unvested, will automatically terminate and become void. The Omnibus Plan further provides that upon a participant’s termination of employment without cause, or upon the resignation or retirement of a participant, (i) the Board of Directors may determine, in its sole discretion, that a portion of the PSUs, RSUs and/or DSUs granted to such participant will immediately vest (based on the vesting terms, including, if applicable, achievement of performance criteria, up to the termination date, as determined in the final and sole discretion of the Board of Directors), (ii) all unvested options will be forfeited, and (iii) vested options will remain exercisable until the earlier of 90 days (30 days for a resignation or retirement) after the termination date or the expiration date of the options. Finally, upon a participant’s termination of employment as a result of death or disability, except as otherwise determined by the Board of Directors, (i) all rights, title and interest in the options granted to such participant which are unvested will continue to vest in accordance with the terms of the Omnibus Plan and the participant’s grant agreement, for a period of up to two years, (ii) vested options (including such options that vest during the period following the termination date) will remain exercisable until the earlier of (A) two years after the termination date, and (B) the expiry date of the options, and (iii) a portion of PSUs, RSUs and/or DSUs granted to the participant will immediately vest, as determined by the Board of Directors.
Amendments and Termination. The Omnibus Plan terminates in accordance with its terms on the 10th anniversary of the date it was adopted by the Board of Directors. The Board of Directors is entitled to suspend or terminate the Omnibus Plan at any time, or from time to time amend or revise the terms of the Omnibus Plan or of any granted award, provided that no such suspension, termination, amendment or revision will be made, (i) except in compliance with applicable laws and with the prior approval, if required, of the shareholders, the NYSE and/or TSX or any other regulatory body having authority over Lion, and (ii) if it would adversely alter or impair the rights of any participant, without the consent of the participant except as permitted by the terms of the Omnibus Plan.
41
The Board of Directors will be required to obtain shareholder approval to make the following amendments:
•except for adjustments permitted by the Omnibus Plan, any reduction in the exercise price of an option or any cancellation of an option and replacement of such option with an option with a lower exercise price, to the extent such reduction or replacement benefits an insider;
•any increase in the maximum number of Common Shares issuable pursuant to the Omnibus Plan, including any amendment to the maximum number of Common Shares expressed as a fixed percentage;
•any increase in the maximum number of Common Shares that may be issuable to insiders pursuant to the insider participation limit;
•any extension of the term of an award beyond its original expiry date, to the extent such amendment benefits an insider;
•any amendment which increases the maximum number of Common Shares that may be issuable upon exercises of options issued under the Omnibus Plan as incentive stock options intended to meet the requirements of Section 422 of the U.S. Internal Revenue Code of 1986;
•any amendment to the Omnibus Plan’s amendment provisions; and
•any amendment which modifies the definition of eligible participant used for purposes of determining eligibility for the grant of any award under the Omnibus Plan.
Except as specifically provided in a grant agreement approved by the Board of Directors, awards granted under the Omnibus Plan will generally not be transferable other than by will or the laws of succession.
Legacy Plan
General. The Company has previously granted options to acquire Common Shares to certain directors, officers and employees of the Company and its subsidiaries under the Legacy Option Plan. The Legacy Plan was originally adopted in November 2017, and subsequently amended and restated in December 2019. In May 2021, Lion made certain amendments to the Legacy Plan to take into account, among other things, the fact that the Common Shares were traded on the NYSE and the TSX. The options issued under the Legacy Plan were granted at exercise prices equal to or exceeding the fair market value of the underlying shares at the time of initial grant. Following adoption of the Omnibus Plan, no further awards were nor will be made under the Legacy Plan; however, awards outstanding under the Legacy Plan continue in full effect in accordance with their existing terms. The Legacy Plan includes terms and conditions required by the TSX for an equity incentive plan such as restrictions relating to amendments of the plan and restrictions on insider participation.
The Board of Directors administers the Legacy Plan and has full authority and discretion to administer and interpret the Legacy Plan and to prescribe such rules and regulations and make such other determinations as it deems necessary or useful for the administration of the Legacy Plan.
Share Reserve. The maximum number of Common Shares reserved for issuance under the Legacy Plan is 12,854,615. As discussed under the section entitled "Omnibus Plan" above, the maximum number of Common Shares available for issuance, in the aggregate, under the Omnibus Plan and the Legacy Plan shall not exceed ten percent (10%) of the aggregate number of Common Shares issued and outstanding from time to time (calculated on a non-diluted basis). As of December 31, 2021, options to purchase 8,777,295 Common Shares at exercise prices ranging from $0.7332 (C$0.9335) to $5.66 were outstanding under the Legacy Plan.
Capital Reorganization. In the event of any reorganization, change in the number of issued and outstanding Common Shares by reason of any stock dividend, stock split, recapitalization, merger, or exchange of shares or other similar corporate change, an equitable adjustment will be made by the Board of Directors in the number and/or kind of shares subject to outstanding options under the Legacy Plan and in the exercise price of such outstanding options.
42
Trigger Events; Change of Control. The Legacy Plan provides that certain events, including termination for cause, resignation, termination other than for cause, retirement, death or disability, may trigger forfeiture or reduce the vesting period, where applicable, of outstanding stock options. In the event of a change of control, the Board of Directors will have the right to accelerate the vesting of any unvested options in connection with such change of control. Except as otherwise set forth in any document evidencing a grant of any option, in the event of any change of control transaction in which there is an acquiring or surviving entity, the Board of Directors may provide for substitute or replacement options of similar value from, or the assumption of outstanding options by, the acquiring or surviving entity or one or more affiliates of such entity, any such substitution, replacement or assumption to be on such terms as the Board of Directors in good faith determines. The Board of Directors will be entitled to, in its sole discretion, terminate any or all stock option outstanding, provided that any such stock option that have vested will remain exercisable until consummation of such change of control.
Other Benefits
The Named Executive Officers are eligible to participate in benefits available generally to salaried employees, including health, dental, life and disability insurance benefits on the same terms as all other employees.
Hedging / Anti-Hedging Policy
The NEOs and the directors are, under the terms of the Company’s insider trading policy, prohibited from engaging in any hedging or monetization activities including, without limitation, any use of financial instruments (such as options, puts, calls, forward contracts, futures, swaps, collars or units of exchange funds) or any other transactions that are designed to hedge or offset a decrease in the market value of any Common Shares or other Lion securities beneficially owned by an NEO or director, directly or indirectly, or in the value of any equity-based compensation awards of an NEO or director (such as stock options, deferred share units, restricted share units and performance share units).
Compensation Risk Management
The Board and the Human Resources and Compensation Committee consider the implications of the risks associated with Lion's compensation policies and practices as part of their respective responsibilities related to overseeing matters related to executive and director compensation.
The Company’s current compensation structure attempts to ensure that compensation and incentive plans do not promote unwanted behavior and unnecessary risk-taking based on, amongst other things:
•a reasonable balance of fixed and variable compensation, and an appropriate mix of share-based compensation and short and long-term compensation;
•qualitative and quantitative metrics used to form a balanced scorecard to determine the amounts of awards to NEOs with respect to the STIP and the LTIP;
•share ownership requirements requiring outside directors to maintain a meaningful equity ownership in the Company;
•a prohibition on the hedging of equity-based compensation;
•policies and practices being generally applied on a consistent basis to all executive officers;
•services rendered by external consultants ensures that the Human Resources and Compensation Committee gets an independent opinion on Lion’s executive compensation program;
•an annual market review of executive compensation to ensure continued relevance, effectiveness and alignment with the Company’s compensation objectives; and
43
•a Human Resources and Compensation Committee composed of a majority of independent directors.
After considering the overall policies and practices applicable to all employees, including the NEOs, the Human Resources and Compensation Committee did not identify any risks arising from the Company's compensation policies and practices that would be reasonably likely to have a material adverse effect on the Company.
Performance Results
Given that the Common Shares have only been publicly traded since May 7, 2021, there is insufficient historical data to provide a relevant performance graph showing the Company’s cumulative total shareholder return over a given period of time versus the trend in the Company’s compensation to executive officers over the same period.
Summary Compensation Table
The following table sets forth information concerning the compensation paid by the Company to the NEOs for the fiscal years ended December 31, 2021 and December 31, 2020.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Name and Principal Position | Fiscal Year | Base Salary ($)(1), (2) | Share-Based Awards ($)(1), (3) | Option- Based Awards ($)(1), (4) | Non-Equity Incentive Plan Compensation | Pension Value ($) | All Other Compensation ($)(1), (6) | Total Compensation ($) |
Annual Incentive Plan ($)(1), (5) | Long-Term Incentive Plans ($) |
Marc Bedard CEO— Founder | 2021 | 391,291 | ― | ― | 195,823 | ― | ― | ― | 587,114 |
2020 | 215,991 | ― | ― | ― | ― | ― | 3,557 | 219,548 |
Nicolas Brunet Executive Vice President and Chief Financial Officer | 2021 | 286,698 | ― | ― | 108,697 | ― | ― | ― | 395,395 |
2020 | 196,356 | ― | ― | ― | ― | ― | ― | 196,356 |
François Duquette(7) Chief Legal Officer and Corporate Secretary | 2021 | 167,316 | 59,141 | 59,164 | 42,595 | ― | ― | ― | 328,216 |
2020 | ― | ― | ― | ― | ― | ― | ― | ― |
Nathalie Giroux(8) Chief People Officer | 2021 | 95,566 | 142,015 | 141,983 | 76,423 | ― | ― | 78,880 | 534,867 |
2020 | ― | ― | ― | ― | ― | ― | ― | ― |
Brian Piern(9) Chief Commercial Officer | 2021 | 129,808 | 175,854 | 1,960,92010 | 39,900 | ― | ― | 88,781 | 2,395,263 |
2020 | ― | ― | ― | ― | ― | ― | ― | ― |
(1) The base salaries, share-based awards, option-based awards, annual incentive and all other compensation of Messrs. Bedard, Brunet, Duquette and Ms. Giroux are paid in Canadian dollars. Mr. Piern's compensation is paid in U.S. dollars. Except where otherwise noted, the amounts reported in the above table for Messrs. Bedard, Brunet, Duquette and Ms. Giroux have been converted to U.S. dollars (i) in the case of amounts relating to Fiscal 2021, at an exchange rate of C$1.00 = US$0.7888, being the daily rate of exchange posted by the Bank of Canada for conversion of Canadian dollars into U.S. dollars on December 31, 2021, and (ii) in the case of amounts relating to Fiscal 2020, at an exchange rate of C$1.00 = US$0.7854, being the daily rate of exchange posted by the Bank of Canada for conversion of Canadian dollars into U.S. dollars on December 31, 2020.
(2) The amounts reported in this column represent the earned base salary received by each NEO in the applicable fiscal year. For Fiscal 2021, the earned base salary received for NEOs who are paid in Canadian dollars was C$496,058 for Mr. Bedard, C$363,461 for Mr. Brunet, C$212,115 for Mr. Duquette and C$121,154 for Ms. Giroux.
(3) The amounts reported in this column represent the grant date fair value of RSUs granted to NEOs under the Omnibus Plan. The grant date fair value was determined in compliance with IFRS 2, Share-based Payment and based on the volume weighted average trading price of the Common Shares on the TSX or the NYSE, as applicable, for the five days immediately preceding the grant date. During Fiscal 2021, the RSU grants reported in this column were made to each of Mr. Duquette, Ms. Giroux and Mr. Piern as an inducement for each of them to enter into a full-time employment agreement with the Company.
44
(4) The amounts reported in this column represent the estimated grant date fair value of options granted under the Omnibus Plan during Fiscal 2021 to Mr. Duquette, Ms. Giroux and Mr. Piern as an inducement for each of them to enter into a full-time employment agreement with the Company. The amounts reported in this column do not represent cash received by the optionees, and the actual value realized upon the future vesting and exercise of such options may be less or greater than the grant date fair values indicated in this column. Amounts shown have been calculated using the Black-Scholes method based on the volume weighted average trading price on the TSX or the NYSE, as applicable, for the five trading days prior to the grant date. The Black-Scholes method is used to estimate the grant date fair value of option-based awards because it is the most commonly used share-based award pricing model and is considered to produce a reasonable estimate of fair value. The assumptions used to measure the fair value of the options granted during Fiscal 2021 under the Black-Scholes method at the grant date were as follows:
| | | | | | | | | | | |
| June 28, 2021 Grant (Canadian) | June 28, 2021 Grant (U.S.) | August 24, 2021 Grant |
Dividend yield | 0% | 0% | 0% |
Expected volatility | 40% | 40% | 40% |
Risk-free interest rate | 1.42 | 1.25 | 1.16 |
Expected option term | 7.5 | 7.5 | 7.5 |
Black-Scholes Value | 8.125 | 8.289 | 5.38 |
(5) The amounts reported in this column represent the annual cash bonuses awarded to each NEO under the STIP for services rendered in each fiscal year as described in "Executive Compensation ― Discussion and Analysis ― Principal Elements of Compensation ― Annual Short-Term Incentive Program (STIP)". For Fiscal 2021, the cash bonus awarded under the STIP to NEOs who are paid in Canadian dollars was C$248,254 for Mr. Bedard, C$137,800 for Mr. Brunet, C$54,000 for Mr. Duquette and C$96,885 for Ms. Giroux.
(6) Perquisites and other personal benefits which, in the aggregate, are worth less than C$50,000 or 10% of the total salary of a NEO are not included under "All Other Compensation". For Fiscal 2021, the payments made to Mr. Piern include (i) a car allowance of $6,923, and (ii) an amount of $81,858 related to relocation and (ii) the payments made to Ms. Giroux represent a lump sum signing bonus of C$100,000 in connection with the signing of her employment agreement with the Company. Mr. Bedard received a car allowance in Fiscal 2021 and Fiscal 2020, and Mr. Duquette received a car allowance in Fiscal 2021.
(7) Mr. Duquette was appointed as Chief Legal Officer and Corporate Secretary of the Company on April 12, 2021 and did not earn any compensation from the Company prior to such date. On June 28, 2021, Mr. Duquette was awarded 7,282 options and 3,257 RSUs under the Omnibus Plan as an inducement to enter into a full-time employment agreement with the Company.
(8) Ms. Giroux was appointed as Chief People Officer of the Company on August 9, 2021 and did not earn any remuneration from the Company prior to such date. On August 24, 2021, Ms. Giroux was awarded 26,389 options and 11,653 RSUs under the Omnibus Plan as an inducement to enter into a full-time employment agreement with the Company.
(9) Mr. Piern was appointed as Chief Commercial Officer of the Company on June 7, 2021 and did not earn any remuneration from the Company prior to such date. On June 28, 2021, Mr. Piern was awarded 236,569 options and 9,409 RSUs under the Omnibus Plan as an inducement to enter into a full-time employment agreement with the Company.
(10) Represents 236,569 options granted to Mr. Piern under the Omnibus Plan as an inducement to enter into a full-time employment agreement with the Company. As of December 31, 2021, none of the options granted to Mr. Piern during Fiscal 2021 were in-the-money. See “Incentive Plan Awards - Outstanding Share-Based Awards and Option-Based Awards Table".
45
Incentive Plan Awards
Outstanding Share-Based Awards and Option-Based Awards Table
The following table summarizes, for each of the NEOs, the number of option-based and share-based awards which were outstanding as at December 31, 2021, being the last day of Fiscal 2021.
| | | | | | | | | | | | | | | | | | | | | | | |
| Option-Based Awards | Share-Based Awards |
Name | Number of Securities Underlying Unexercised Options (#)(1) | Option Exercise Price ($)(2) | Option Expiration Date | Value of Unexercised In-the-Money Options ($)(3) | Number of Shares or Units of Shares that have not Vested (#)(4) | Market or Payout Value of Share-Based Awards that have not Vested ($)(5) | Market or Payout Value of Vested Share-Based Awards not Paid out or Distributed ($) |
Marc Bedard | 314,936 | 0.74 | 2029/06/14 | 2,871,753 | — | — | — |
| 2,641,439 | 0.74 | 2027/11/01 | 24,086,036 | — | — | — |
Nicolas Brunet | 2,245,917 | 0.74 | 2029/12/26 | 20,479,457 | — | — | — |
François Duquette | 7,282 | 18.16 | 2031/04/12 | — | 3,257 | $32,114 | — |
Nathalie Giroux | 26,389 | 12.19 | 2031/08/09 | — | 11,653 | $114,899 | — |
Brian Piern | 236,569 | 18.69 | 2031/06/07 | — | 9,409 | $93,525 | — |
(1) Represents the number of vested and unvested unexercised options.
(2) All options included in this table, to the exception of options granted to Mr. Piern’s, have an exercise price in Canadian dollars. The conversion price for such options has been converted to U.S. dollars at an exchange rate of C$1.00 = US$0.7888, being the daily rate of exchange posted by the Bank of Canada for conversion of Canadian dollars into U.S. dollars on December 31, 2021.
(3) Options are in-the-money if the market value of the Common Shares underlying the options is greater than the option exercise price. The value shown is equal to the excess, if any, of the Common Share closing price on the TSX or NYSE (being C$12.50 and $9.94, respectively), as applicable, on December 31, 2021, over the option’s exercise price. The actual value realized will be based on the actual in-the-money value upon exercise of the options, if any. The options vest in 25% tranches over a period of four years beginning on the first anniversary date of (i) the date of hire with respect to options granted to Mr. Duquette, Ms. Giroux and Mr. Piern or (ii) the date of grant with respect to options granted to Mr. Bedard and Mr. Brunet.
(4) Represents shares underlying RSUs granted to NEOs under the Omnibus Plan. RSUs vest on the third anniversary of the date of hire for Mr. Duquette, Ms. Giroux and Mr. Piern.
(5) Value is based on the Common Share closing price on December 31, 2021 on the TSX or NYSE (being C$12.50 and $9.94, respectively), as applicable. The market or payout value of share-based awards that have not vested for all NEOs, except for Mr. Piern, has been calculated in Canadian dollars and converted to U.S. dollars at an exchange rate of C$1.00 = US$0.7888, being the daily rate of exchange posted by the Bank of Canada for conversion of Canadian dollars into U.S. dollars on December 31, 2021.
Incentive Plan Awards – Value Vested or Earned During the Year
The following table provides, for each of the NEOs, a summary of the value of the option-based and share-based awards vested or non-equity incentive plan compensation earned during Fiscal 2021:
| | | | | | | | | | | |
Name | Option-Based Awards – Value Vested During the Year ($)(1) | Share-Based Awards – Value Vested During the Year ($) | Non-Equity Incentive Plan Compensation – Value Earned During the Year ($)(2) |
Marc Bedard | 13,101,600 | — | 195,823 |
Nicolas Brunet | 5,865,815 | — | 108,697 |
François Duquette | — | — | 42,595 |
Nathalie Giroux | — | — | 76,423 |
Brian Piern | — | — | 39,900 |
(1) Calculated as the difference between the market price of the Common Shares on the date of vesting or the last trading day prior to vesting, if applicable, and the exercise price payable in order to exercise the options.
(2) Amounts are equal to those shown in the “Non-Equity Incentive Plan Compensation – Annual Incentive Plans” column in the Summary Compensation Table.
46
Summary of NEO Employment Agreements
We have entered into an employment agreement with each of Lion's Named Executive Officers. Each employment agreement has an indefinite term. The material terms of each of our NEO employment agreements follow:
Marc Bedard
In May 2015, Marc Bedard entered into an employment agreement with Lion. Mr. Bedard’s employment with Lion will continue until terminated in accordance with the terms of the employment agreement. The employment agreement provides for (1) a base salary; and (2) an annual performance bonus. Mr. Bedard is also entitled to participate in the Company's long term incentive plan. The employment agreement provides Mr. Bedard with potential severance benefits if his employment with Lion is terminated for any reason other than (i) death, (ii) insolvency or bankruptcy, (iii) permanent or long-term incapacity or disability, (iv) for cause or (v) Mr. Bedard's voluntary resignation or his retirement, in a maximum amount equivalent to 24 months of his then current annual base salary, paid in lump sum. Under his employment agreement, Mr. Bedard is subject to non-competition obligations during and for two years following his termination of employment, is subject to restrictions on soliciting Lion’s employees during and for three years following his termination of employment, and is subject to confidentiality and intellectual property assignment covenants.
Nicolas Brunet
On December 11, 2019, Nicolas Brunet entered into an employment agreement with Lion to serve as Executive Vice-President and Chief Financial Officer of Lion. Mr. Brunet’s employment with Lion will continue until terminated in accordance with the terms of the employment agreement. The employment agreement provides for (1) a base salary; (2) an annual performance bonus; and (3) participation in the Company's long term incentive plan. The employment agreement provides Mr. Brunet with potential severance benefits if his employment with Lion is terminated without cause, in a maximum amount equivalent to 12 months of its then current annual base salary, paid in lump sum. Under his employment agreement, Mr. Brunet is subject to restrictions on soliciting Lion’s employees during and following his termination of employment, and is subject to confidentiality and intellectual property assignment covenants.
François Duquette
On March 8, 2021, François Duquette entered into an employment agreement with Lion to serve as Chief Legal Officer and Corporate Secretary of Lion. Mr. Duquette’s employment with Lion will continue until terminated in accordance with the terms of the employment agreement. The employment agreement provides for (1) a base salary; (2) an annual performance bonus; and (3) participation in the Company's long term incentive plan. The employment agreement provides Mr. Duquette with potential severance benefits if his employment with Lion is terminated without cause, in a maximum amount equivalent to 12 months of its then current annual base salary, paid in lump sum. Under his employment agreement, Mr. Duquette is subject to non-competition obligations during and for 12 months following his termination of employment, is subject to restrictions on soliciting Lion’s employees, clients and suppliers during and for 12 months following his termination of employment, and is subject to confidentiality and intellectual property assignment covenants.
Nathalie Giroux
On July 1, 2021, Ms. Giroux entered into an employment agreement with Lion to serve as Chief People Officer of Lion. Ms. Giroux's employment with Lion will continue until terminated in accordance with the
47
terms of the employment agreement. The employment agreement provides for (1) a base salary; (2) an annual performance bonus; (3) participation in the Company's long-term incentive plan; and (4) a signing bonus comprised of stock options and a cash bonus. The employment agreement provides Ms. Giroux with potential severance benefits if her employment with Lion is terminated without cause, in a maximum amount equivalent to 12 months of her then current annual base salary, paid in lump sum. Under her employment agreement, Ms. Giroux is subject to non-competition obligations during and for 12 months following her termination of employment, is subject to restrictions on soliciting Lion’s employees, client and suppliers during and for 12 months following termination of employment, and is subject to confidentiality and intellectual property assignment covenants.
Brian Piern
On May 2, 2021, Brian Piern entered into an employment agreement with Lion to serve as Chief Commercial Officer of Lion. Mr. Piern’s employment with Lion will continue until terminated in accordance with the terms of the employment agreement. The employment agreement provides for (1) a base salary; (2) an annual performance bonus; (3) participation in the Company's long-term incentive plan; (4) an initial grant of stock options and RSUs; (5) a signing bonus in the form of stock options; and (6) certain other perquisites. The employment agreement provides Mr. Piern with potential severance benefits if his employment with Lion is terminated without cause, in a maximum amount equivalent to 12 months of its then current annual base salary, paid in lump sum. Under his employment agreement, Mr. Piern is subject to non-competition obligations during and for 12 months following his termination of employment, is subject to restrictions on soliciting Lion’s employees, clients and suppliers during and for 12 months following his termination of employment, and is subject to confidentiality and intellectual property assignment covenants.
Severance on Termination of Employment
Employment of an NEO can be terminated by any of the following means: resignation by the executive, termination by the Company for cause, termination by the Company other than for cause, the retirement of the executive or disability or death of the executive. Severance entitlements are set out in individual NEO employment agreements and the Omnibus Plan and Legacy Plan.
48
The following table sets forth estimates of the minimum amounts payable to each of the NEOs who were employed by the Company as at the end of Fiscal 2021 upon the occurrence of certain events as of December 31, 2021:
| | | | | | | | | | | |
Name of the NEO | Termination other than for Cause ($)(1) | Voluntary Resignation, Retirement ($) | Termination for Cause ($) |
Marc Bedard Salary/Severance RSUs Options |
954,448 — — |
— — — |
— — — |
Nicolas Brunet Salary/Severance RSUs Options |
335,240 — — |
— — — |
— — — |
François Duquette Salary/Severance RSUs Options |
276,080 — — |
— — — |
— — — |
Nathalie Giroux Salary/Severance RSUs Options |
236,640 — — |
— — — |
— — — |
Brian Piern Salary/Severance RSUs Options |
225,000 — — |
— — — |
— — — |
(1) Termination other than for cause includes termination other than for cause following a Change of Control. Amounts exclude all vested in-the-money options which were outstanding as of December 31, 2021.
A NEO is not entitled to receive any payment under the STIP relating to a partially completed financial year if the effective date of his or her termination (with or without cause) or resignation occurs prior to the end of the fiscal year in respect of which the payout under the STIP is calculated. Moreover, upon an NEO's termination of employment without cause, or upon the resignation or retirement of an NEO, the Board may determine, in its sole discretion, that (i) a portion of the awards granted to such NEO will immediately vest, (ii) all unvested options will be forfeited, and (iii) vested options will remain exercisable until the earlier of 90 days (30 days for a resignation or retirement) after the termination date or the expiration date of the options. In addition, except as otherwise determined by the Board, on the effective date of a NEO’s termination for cause, all such NEO’s vested and unvested options are forfeited and all his or her other benefits are terminated. For additional discussion on the various provisions that apply upon termination of employment of a NEO or a change of control of the Company see "Executive Compensation – Long-Term Incentive Plans (LTIP)".
49
Securities Authorized for Issuance under Equity Compensation Plans
The following table provides a summary, as of December 31, 2021, of the security-based compensation plans or individual compensation arrangements pursuant to which equity securities of the Company may be issued:
| | | | | | | | | | | |
Plan Category(1) |
Number of Securities to be Issued upon Exercise of Outstanding Options, RSUs or DSUs (#) |
Weighted-Average Exercise Price of Outstanding Options ($) | Number of Securities Remaining Available for Future Issuance under Equity Compensation Plans (Excluding Securities Appearing in Second Column) (#) |
Legacy Plan
| Options: 8,777,295 | C$1.15 | 9,873,120 |
Omnibus Plan | Options: 294,854 DSUs: 18,755 RSUs: 36,247 | C$21.86 - - |
Total | 9,127,151 | C$1.81 | 9,873,120 |
(1) See "Executive Compensation ― Equity Incentive Plans” for a description of the Legacy Plan and Omnibus Plan.
50
DISCLOSURE OF CORPORATE GOVERNANCE PRACTICES
The Canadian securities regulatory authorities have issued corporate governance guidelines pursuant to National Policy 58-201—Corporate Governance Guidelines (the "Corporate Governance Guidelines"), together with certain related disclosure requirements pursuant to National Instrument 58-101—Disclosure of Corporate Governance Practices ("NI 58-101"). The Corporate Governance Guidelines are recommended as “best practices” for issuers to follow. Lion recognizes that good corporate governance plays an important role in its overall success and in enhancing shareholder value and, accordingly, Lion has adopted certain corporate governance policies and practices which reflect its consideration of the recommended Corporate Governance Guidelines. The disclosure set out below describes the Company’s approach to corporate governance.
Board of Directors
Board of Directors Size
The Board of Directors is currently comprised of seven directors, all of which are standing for re-election at the Meeting and one director nominee is standing for election for the first time at the Meeting. See "Election of Directors" – "Description of Proposed Director Nominees ". The Board of Directors is of the view that its size and its composition are adequate and allow for the efficient functioning of the Board of Directors as a decision-making body.
Independence
Under the NYSE Listing Rules, an independent director means a person who, in the opinion of Lion’s Board, has no material relationship with Lion. Under NI 58-101, a director is considered to be independent if he or she is independent within the meaning of Section 1.4 of National Instrument 52-110—Audit Committees ("NI 52-110"). Pursuant to NI 52-110, an independent director is a director who is free from any direct or indirect material relationship with Lion which could, in the view of Lion’s Board, be reasonably expected to interfere with the exercise of such director’s independent judgement. Lion’s Board agrees with this approach to assessing director independence.
Based on information provided by each director and nominee director concerning his or her background, employment and affiliations, Lion’s Board has determined that as at March 25, 2022, four out of the seven current directors are considered independent as that term is defined under the NYSE Listing Rules and NI 58-101, namely Ms. Sheila C. Bair and Messrs. Michel Ringuet, Lorenzo Roccia and Pierre Wilkie. Ann L. Payne, who will stand for election for the first time at the Meeting, is also considered independent, such that on May 6, 2022, assuming the election of all proposed director nominees at the Meeting, the Board of Directors will be comprised of eight (8) directors with five (5) of them being independent as that term is defined under the NYSE Listing Rules and NI 58-101. In making this determination, Lion’s Board considered the current and prior relationships that each such non-employee director has with Lion and all other facts and circumstances that Board deemed relevant in determining their independence.
Furthermore, all members of the Audit Committee of the Board of Directors are considered independent as that term is defined under the NYSE Listing Rules and NI 58-101 and each committee is chaired by an independent chair.
Marc Bedard is considered non-independent due to the fact that he acts as the CEO–Founder of Lion. Pierre Larochelle and Pierre-Olivier Perras are considered non-independent under the NYSE Listing Rules and NI 58-101 due to their relationship with Power Sustainable and Power Energy, respectively.
Six of the seven current members of the Board, as well as the new proposed nominee, are not members of Lion’s management. Lion’s Board believes that, except for Mr. Bedard, all of the individuals who serve on Lion’s Board or who will be standing for election at the Meeting are independent of management, and have no other relationships that could reasonably interfere with the exercise of their independent judgment in discharging their duties to Lion. The following table shows which directors or
51
proposed directors are not considered independent within the meaning of the NYSE Listing Rules and NI 58-101, and the reason for such non-independence of individual directors.
| | | | | | | | | | | |
NAME |
WITHIN THE NYSE LISTING RULES AND NI 58-101 | REASON FOR NON-INDEPENDENCE |
| Independent | Not Independent | |
Marc Bedard | | ü | Mr. Bedard is not independent as he is the CEO—Founder of the Company. |
Sheila C. Bair | ü | | |
Pierre Larochelle | | ü | Mr. Larochelle is not independent due to his current advising role with Power Sustainable. |
Ann L. Payne | ü | | |
Pierre-Olivier Perras | | ü | Mr. Perras is not independent as he is an executive of Power Energy. |
Michel Ringuet | ü | | |
Lorenzo Roccia | ü | | |
Pierre Wilkie | ü | | |
Lion’s Board believes that given its size and structure, it is able to facilitate independent judgement in carrying out its responsibilities. To enhance such independent judgement, the independent members of Lion’s Board may meet in the absence of non-independent directors and members of management. The independent directors of the Company consider, at each meeting, whether an in camera meeting without the non-independent directors and members of management would be appropriate, and may hold an in camera meeting where appropriate. In addition, any independent director may, at any time, if considered necessary to facilitate open and candid discussion among the independent directors, call a meeting or request an in camera session without management and non-independent directors. During Fiscal 2021, the Board of Directors did not hold any in camera sessions, and the Audit Committee held three (3) in camera sessions where members met without non-independent directors and members of management.
In addition, considering that the Chairman of the Board of Directors is considered non-independent, Mr. Michel Ringuet was appointed by the Board of Directors to serve as independent Lead Director in order to ensure appropriate leadership for the independent directors. Lion’s Board adopted a written position description for the Lead Director. His primary functions are to provide leadership to the directors to enhance the effectiveness and independence of the Board of Directors, to facilitate the efficient functioning of the Board of Directors, to ensure that there is an effective relationship between management and the members of the Board of Directors and to advise the Chairman of the Board of Directors on the appropriate flow of information to the Board of Directors.
For purposes of managing any potential conflicts of interest, a director who has a material interest in a matter before Lion’s Board or any committee on which he or she serves is required to disclose such interest as soon as the director becomes aware of it. In situations where a director has a material interest in a matter to be considered by Lion’s Board or any committee on which he or she serves, such director may be required to absent himself or herself from the meeting while discussions and voting with respect to the matter are taking place. Directors are also required to comply with the relevant provisions of the Business Corporations Act (Québec) regarding conflicts of interest.
Directorship of Other Reporting Issuers
Some members of the Company’s Board of Directors are also members of the boards of other public companies. See "Business of the Meeting - Election of Directors - Description of Proposed Director Nominees". The Board of Directors has not adopted a director interlock policy but is keeping informed of other public directorships held by its members. As at March 25, 2022, none of the Company’s directors served together on any other public company’s board of directors.
52
Mandate of the Board of Directors
Lion’s Board is responsible for supervising the management of Lion’s business and affairs, including providing guidance and strategic oversight to management. The Board of Directors holds regularly scheduled meetings as well as ad hoc meetings from time to time. Lion’s Board has adopted a formal mandate that includes the following:
•ensuring a strategic planning process is in place and reviewing, on at least an annual basis, the principal business objectives for the Company and monitoring the Company’s success in implementing the strategy and achieving its goals;
•appointing the Chief Executive Officer of the company and developing the corporate goals and objectives that the Chief Executive Officer is responsible for meeting, and reviewing the performance of the Chief Executive Officer against such goals and objectives;
•overseeing communications with shareholders, other stakeholders, analysts and the public, including the adoption of measures for receiving feedback from stakeholders and reporting to shareholders as necessary; and
•monitoring the implementation of procedures, policies and initiatives relating to corporate governance, risk management, corporate social responsibility, health and safety, ethics and integrity.
Under its mandate, the Board of Directors is entitled, among other things, to delegate certain matters it is responsible for to Board of Directors' committees. The text of the Board of Director’s mandate is attached to this Circular as Schedule A.
Position Descriptions
Chairman of the Board of Directors and Committee Chairs
Lion’s Board adopted written position descriptions for the Chairman of Lion’s Board and the chairperson of the board committees. Their primary roles are to manage the affairs of Lion’s Board or of such relevant committee, including ensuring Lion’s Board or such committee is organized properly, functions effectively and meets its obligations and responsibilities. Each committee has a chairperson that conducts the affairs of the applicable committee in accordance with the charter of such committee. In addition, Lion’s Board adopted a written position description for the Lead Director of the Board of Directors as further described in "Disclosure of Corporate Governance Practices—Board of Directors—Independence".
Lion’s Board and CEO—Founder have not developed at this time a written position description for the CEO—Founder or for other executive officers. The role of the CEO—Founder is delineated on the basis of customary practice. Lion’s Board considers that the role and responsibilities of the CEO—Founder are to develop the company’s strategic plans and policies and recommending such plans and policies to Lion’s Board, provide executive leadership, oversee a comprehensive operational planning and budgeting process, supervise day-to-day management, report relevant matters to Lion’s Board, facilitate communications between Lion’s Board and the senior management team, and identify business risks and opportunities and manage them accordingly, and has communicated the same to the CEO—Founder.
Nomination of Directors
Pursuant to the Nomination Rights Agreement, each of Power Energy and 9368-2672 will, for so long as it and its affiliates collectively hold at least 20% of the outstanding Common Shares (on a non-diluted basis), be entitled to designate a number of director nominees equal to the product of (rounding to the nearest whole number) (i) the percentage of the outstanding Common Shares held by it (on a non-diluted basis) multiplied by (ii) the size of Lion’s Board. In addition, 9368-2672 will, for so long as it and its
53
affiliates collectively hold at least 5% of the outstanding Common Shares (on a non-diluted basis), be entitled to designate (i) for so long as Marc Bedard serves as chief executive officer of Lion, one director nominee (in addition to Marc Bedard, who will be appointed to Lion’s Board for so long as he serves as chief executive officer thereof) and (ii) at any other time, Marc Bedard as a director nominee. See "Disclosure of Corporate Governance Practices ― Nomination Rights Agreement" for a summary description of the rights contained in the Nomination Rights Agreement.
The Nominating and Corporate Governance Committee is responsible for Board and committee succession planning and for making annual recommendations to the Board regarding the size and composition of its committees. It also proposes new nominees for election as director. The Nominating and Corporate Governance Committee will consider the competencies and skills that the Board considers to be necessary for the Board as a whole to possess, the competencies and skills that the Board considers each existing director to possess, and the competencies and skills each new nominee will bring to the boardroom in making recommendations for director nominations.
Board Evaluation
Lion’s Nominating and Corporate Governance Committee is responsible for overseeing the evaluation of Lion’s Board and its committees and, in that respect, the Committee assesses the contribution of each director on an ongoing basis and in light of the opportunities and risks facing the Company, as well as the skills and competencies requirement of directors. Moreover, each director is required, annually, to complete a confidential written evaluation with respect to the performance of the Board and the performance of its Committees.
Orientation and Continuing Education
The Company recognizes ongoing director education as an important component of good governance. Directors ensure to be informed about current best practices, emerging trends in corporate governance and relevant regulatory developments. The Nominating and Corporate Governance Committee is responsible for overseeing director continuing education designed to maintain or enhance the skills and abilities of the directors and to ensure that their knowledge and understanding of Lion’s business remains current. The chairperson of each committee is responsible for coordinating orientation and continuing director development programs relating to the committee’s mandate.
Pursuant to the Company's orientation program, each new director will meet upon his or her election to the Board of Directors, separately with the Chairman, individual directors and members of the senior management to familiarize himself or herself with the nature and operation of the Company and its business, the role of Lion's Board and its committees as well as the expected contribution that an individual director is expected to make. A new director will be presented with the Board of Directors policies and procedures, the Company’s current strategic plan, organizational structure, operations, governance and compensation plans, financial plan and capital plan, the most recent core public disclosure documents and other materials relating to key business issues. A new director will also be visiting selected facilities.
Director Term Limits and Other Mechanisms of Board Renewal
The Nominating and Corporate Governance Committee is charged under its charter with selecting candidates for election as independent directors. See "Disclosure of Corporate Governance Practices ― Board of Directors Committees ― Nominating and Corporate Governance Committee".
Lion’s Board has not adopted director term limits or other automatic mechanisms of board renewal. Rather than adopting formal term limits, mandatory age-related retirement policies and other mechanisms of board renewal, the Nominating and Corporate Governance Committee will seek to maintain the composition of Lion’s Board in a way that provides, in the judgement of Lion’s Board, the best mix of skills and experience to provide for Lion’s overall stewardship.
54
Board of Directors Committees
Lion’s Board has three standing committees: the Audit Committee, the Human Resources and Compensation Committee, and the Nominating and Corporate Governance Committee. Each of the committees operates under its own written charter adopted by Lion’s Board, each of which is available on Lion’s website.
Audit Committee
Lion’s Audit Committee is composed of Michel Ringuet, Sheila C. Bair and Pierre Wilkie, with Michel Ringuet serving as chairperson of the committee. Lion’s Board has determined that all such directors meet the independence requirements under the NYSE Listing Rules, NI 52-110 and under Rule 10A-3 of the Exchange Act. Lion complies with NI 52-110 by relying on the exemptions for U.S. listed issuers thereunder. The relevant experience of each member of the Audit Committee is described as part of their respective biographies. See "Business of the Meeting - Election of Directors - Description of Proposed Director Nominees".
The Board of Directors has adopted a written charter describing the mandate of the Audit Committee. The Audit Committee’s responsibilities include:
•appointing, compensating, retaining and overseeing the work of any registered public accounting firm engaged for the purpose of preparing or issuing an audit report or performing other audit, review or attest services and reviewing and appraising the audit efforts of Lion’s independent accountants;
•pre-approving audit and permissible non-audit services, and the terms of such services, to be provided by Lion’s independent registered public accounting firm;
•establishing procedures for (i) the receipt, retention and treatment of complaints regarding accounting, internal accounting controls or auditing matters and (ii) confidential and anonymous submissions by Lion’s employees of concerns regarding questionable accounting or auditing matters;
•engaging independent counsel and other advisers, as necessary and determining funding of various services provided by accountants or advisers retained by the committee;
•reviewing Lion’s financial reporting processes and internal controls;
•establishing, overseeing and dealing with issues related to the Company’s code of ethics for managers and financial officers;
•reviewing and approving related-party transactions or recommending related-party transactions for review by independent members of Lion’s Board; and
•providing an open avenue of communication among the independent accountants, financial and senior management and Lion’s Board.
Additional information relating to the Audit Committee can be found under the Company's profiles on SEDAR at www.sedar.com and on EDGAR at www.sec.gov and on the Company's website at ir.thelionelectric.com.
Human Resources and Compensation Committee
The Human Resources and Compensation Committee is currently composed of Messrs. Wilkie, Perras and Ringuet, with Mr. Wilkie acting as chairperson. The primary purpose of the Human Resources and Compensation Committee, with respect to compensation, is to assist Lion’s Board in fulfilling its
55
oversight responsibilities and to make recommendations to Lion’s Board with respect to the compensation of Lion’s directors and executive officers.
The Board of Directors has adopted a written charter describing the mandate of the Human Resources and Compensation Committee. The principal responsibilities and duties of the Human Resources and Compensation Committee include:
•establishing and reviewing Lion’s overall compensation philosophy;
•evaluating Lion’s CEO—Founder’s and other executive officer’s performance in light of the goals and objectives established by Lion’s board of directors and, based on such evaluation, with appropriate input from other independent members of Lion’s board of directors, determining the CEO—Founder’s and other executive officer’s compensation;
•reviewing management’s assessment of existing management resources and succession plans;
•administering Lion’s equity-based and incentive compensation plans and making recommendations to Lion’s Board about amendments to such plans and the adoption of any new employee incentive compensation plans;
•reviewing executive compensation disclosure before the company publicly discloses this information; and
•engaging independent counsel and other advisers, as necessary and determining funding of various services provided by advisers retained by the committee.
The Company's approach to compensation is described under "Business of the Meeting - Compensation of Directors" and "Business of the Meeting - Executive Compensation ― Discussion and Analysis".
Nominating and Corporate Governance Committee
Lion’s Nominating and Corporate Governance Committee is composed of Sheila C. Bair, Pierre-Olivier Perras and Lorenzo Roccia, with Sheila C. Bair serving as chairperson of the committee. The Board of Directors has adopted a written charter describing the mandate of the Nominating and Corporate Governance Committee. The Nominating and Corporate Governance Committee’s responsibilities include:
•developing and recommending to Lion’s Board criteria for board and committee membership;
•recommending to Lion’s Board the persons to be nominated for election as directors and to each of the committees of Lion’s Board;
•assessing the independence of directors within the meaning of securities laws and stock exchange rules as applicable;
•considering resignations by directors submitted pursuant to Lion’s majority voting policy, and making recommendations to Lion’s Board as to whether or not to accept such resignations;
•reviewing and making recommendations to the board of directors in respect of Lion’s corporate governance principles;
•providing for new director orientation and continuing education for existing directors on a periodic basis;
56
•performing an evaluation of the performance of the committee; and
•overseeing the evaluation of Lion’s Board and its committees.
The following matrix provides a summary of the competencies, skills, experience and expertise that each current director or proposed director nominee possesses as well as other information that may be relevant for purposes of identifying new directors.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Finance and Accounting | Budget Oversight | Environment Expertise | Strategic Planning | Industry Expertise | Human Resources | Business and Management | Marketing and Communications | Legal and Corporate Governance | Risk Management | Information Technology and Cybersecurity | Government relations |
Sheila C. Bair | ü | | | ü | | | | | ü | ü | | ü |
Marc Bedard | ü | ü | | ü | ü | | ü | | | | | ü |
Pierre Larochelle | ü | ü | ü | ü | ü | ü | ü | | ü | | | |
Ann L. Payne | ü | ü | | | | | | | | ü | ü | |
Pierre-Olivier Perras | ü | ü | | | ü | | ü | | ü | | | |
Michel Ringuet | ü | ü | | ü | | | ü | | ü | ü | | |
Lorenzo Roccia | | | ü | ü | ü | ü | ü | ü | | | | ü |
Pierre Wilkie | | ü | | ü | | ü | ü | ü | | | | |
Code of Ethics
The Company has a written code of business conduct and ethics (the "Code of Conduct") applicable to all of its directors, officers and employees. The Code of Conduct sets out Lion’s fundamental values and standards of behavior that are expected from Lion’s directors, officers and employees with respect to all aspects of Lion’s business. The objective of the Code of Conduct is to provide guidelines for maintaining Lion’s integrity, reputation and honesty with a goal of honoring others’ trust in Lion at all times. The Code of Conduct sets out guidance with respect to conflicts of interest, protection and proper use of corporate assets and opportunities, confidentiality of corporate information, fair dealing with third parties, compliance with laws and reporting of any illegal or unethical behavior.
Lion’s audit committee is responsible for reviewing and evaluating the Code of Conduct periodically and recommends any necessary or appropriate changes thereto to Lion’s Board for consideration. The audit committee also assists Lion’s Board with the monitoring of compliance with the Code of Conduct and is responsible for considering any waivers of the Code of Conduct (other than waivers applicable to Lion’s directors or executive officers, which shall be subject to review by Lion’s Board as a whole).
The Company has a Whistleblower Hotline which employees and others can access by phone or online, and choose to report anonymously or not at their option. The chairperson of the Audit Committee is automatically notified of any whistleblower reports and the Audit Committee is provided with periodic updates from management on any whistleblower reports that may have been reported and how they were investigated and resolved.
The Code of Conduct is available under the Company's profile on SEDAR at www.sedar.com, on EDGAR at www.sec.gov. and on the Company's website at ir.thelionelectric.com.
57
Insider Trading Policy
Lion has adopted an insider trading policy which prohibits its executives, other employees and directors from: (i) trading in its securities while in possession of material undisclosed information about Lion; and (ii) entering into certain derivative-based transactions that involve, directly or indirectly, securities of Lion, during a restricted period.
Diversity
Lion recognizes the importance and benefit of having a board of directors and senior management composed of highly talented and experienced individuals having regard to the need to foster and promote diversity among board members and senior management with respect to attributes such as gender, ethnicity and other factors. In support of this goal, the Nominating and Corporate Governance Committee will, when identifying candidates to nominate for election to Lion’s Board or appoint as senior management or in its review of senior management succession planning and talent management:
•consider individuals who are highly qualified, based on their talents, experience, functional expertise and personal skills, character and qualities having regard to Lion’s current and future plans and objectives, as well as anticipated regulatory and market developments;
•consider criteria that promote diversity, including with regard to gender, ethnicity, and other dimensions;
•consider the level of representation of women on its board of directors and in senior management positions, along with other markers of diversity, when making recommendations for nominees to Lion’s Board or for appointment as senior management and in general with regard to succession planning for Lion’s Board and senior management; and
•as required, engage qualified independent external advisors to assist Lion’s Board in conducting its search for candidates that meet the board of directors’ criteria regarding skills, experience and diversity.
The Nominating and Corporate Governance Committee considers the level of representation of directors from diverse backgrounds on the Board of Directors by overseeing the selection process and ensuring that diverse candidates, including women and racial and ethnic minorities, are included in the list of candidates proposed to the Board of Directors as potential directors. The Nominating and Corporate Governance Committee also sets measurable objectives for achieving diversity. In connection with these objectives, the Board of Directors has set the following two targets to be achieved at or prior to the Company's next annual meeting of shareholders to be held in 2023: (i) at least 30% of directors on the Board of Directors should be women and (ii) at least one director should be a minority. Lion currently has one woman on its board of directors and one woman as executive officer, representing 14.3% of Lion’s directors and 16.7% of its senior management team. Two (2) of the eight (8) directors nominees being proposed for election at this year’s Meeting are women. Assuming the election of all nominated directors at the Meeting, women would represent 25% of the Board of Directors.
Nomination Rights Agreement
Pursuant to the Nomination Rights Agreement, each of Power Energy and 9368-2672 were granted certain rights to nominate members of Lion’s Board (including, in certain cases, members of committees of Lion’s Board) for so long as it holds a requisite percentage of the total voting power of Lion. More specifically, each of Power Energy and 9368-2672 will, for so long as it and its affiliates collectively hold at least 20% of the outstanding Common Shares (on a non-diluted basis), be entitled to designate a number of director nominees equal to the product of (rounding to the nearest whole number) (i) the percentage of the outstanding Common Shares held by it (on a non-diluted basis) multiplied by (ii) the size of Lion’s Board.
58
The foregoing rights of Power Energy and 9368-2672 to so designate director nominees will be submitted for approval of the Shareholders at the first annual meeting of the Shareholders to be held following the fifth anniversary of the date of the Nomination Rights Agreement, and at every fifth annual meeting of the Shareholders thereafter. Failing approval by the Shareholders, such nomination rights will become void and shall have no further force or effect.
Notwithstanding any shareholder approval of the nomination rights described above, 9368-2672 will, for so long as it and its affiliates collectively hold at least 5% of the outstanding Common Shares (on a non-diluted basis), be entitled to designate (i) for so long as Marc Bedard serves as chief executive officer of Lion, one director nominee (in addition to Marc Bedard, who will be appointed to Lion’s Board for so long as he serves as chief executive officer thereof) and (ii) at any other time, Marc Bedard as a director nominee.
At least one of each of Power Energy and 9368-2672’s director nominees (other than Marc Bedard), must be an independent director as determined by the Nominating and Corporate Governance Committee, and all director nominees of Power Energy and 9368-2672 must also receive the favorable recommendation of the Nominating and Corporate Governance Committee, having regard to the characteristics, experience, skill set, independence and diversity desired by Lion’s Board. In the even that any of Power Energy or 9368-2672’s director nominees are disqualified for failing to satisfy the foregoing criteria, the affected shareholder shall be entitled to designate a replacement director nominee.
The nomination rights contained in the Nomination Rights Agreement provide that Power Energy and 9368-2672, at the relevant time, will cast all votes to which they are entitled to elect directors designated in accordance with the terms and conditions of the Nomination Rights Agreement.
The Nomination Rights Agreement further provides that for so long as Power Energy has the right to designate a director nominee, it shall have the right to designate one of its director nominees as the Chairman of Lion’s Board. In the event that such designated director nominee is not an independent director, the remaining directors will select a lead independent director from amongst the independent directors of Lion’s Board.
Each of Power Energy and 9368-2672 also has the right under the Nomination Rights Agreement to appoint one member of each committee of Lion’s Board, except that neither Marc Bedard or 9368-2672 has the right to appoint any director to the Human Resources and Compensation Committee, the composition of which shall be determined by the Board of Directors in its sole discretion.
The foregoing description of the Nomination Rights Agreement is qualified in its entirety by reference to the full text of the form of Nomination Rights Agreement, a copy of which can be found under the Company's profiles on SEDAR at www.sedar.com and EDGAR at www.sec.gov.
Majority Voting Policy
The Company does not employ the practice of “slate voting” and, as such, at meetings of shareholders where directors are to be elected, shareholders of the Company are entitled to vote FOR, or to WITHHOLD from voting, separately for each director nominee. The Company ensures that the number of shares voted in favor or withheld from voting for each director nominee is recorded and promptly disclosed after the Meeting.
The Board of Directors adopted a majority voting policy in order to promote enhanced director accountability. The policy stipulates that, in an “uncontested election” (as defined below) of directors, any nominee for director who receives a greater number of votes withheld from his or her election than votes for his or her election will promptly tender his or her resignation to the Chair of the Board of Directors following the shareholder's meeting. Following receipt of such resignation, the Nominating and Corporate Governance Committee will consider such resignation, and recommend to the Board whether or not to accept it.
59
The Board shall act on the Nominating and Corporate Governance Committee's recommendation within 90 days after the date of the relevant shareholders' meeting. The Board will accept the resignation absent exceptional circumstances that would warrant the director to continue to serve on the Board. A press release disclosing the Board of Directors’ determination (and the reasons for rejecting the resignation, if applicable) shall be promptly issued. A copy of such press release shall be sent concurrently to the TSX and the NYSE. The resignation will become effective when accepted by the Board of Directors.
If a resignation is accepted, the Board of Directors may, in accordance with the provisions of the Business Corporations Act (Québec), the constating documents of the Company, applicable securities laws and regulation and applicable agreements, including the Nomination Rights Agreement, appoint a new director to fill any vacancy created by the resignation, reduce the size of the Board, leave any vacancy open until the next annual general meeting of the shareholders, call a special meeting of shareholders at which nominees will be presented to fill any vacancies, or any combination of the above.
The policy only applies in circumstances involving an uncontested election of directors. For purposes of the majority voting policy, an “uncontested election” means an election where the number of nominees for directors equals the number of directors to be elected.
Advance Notice Requirements for Director Nominations
The Company's by-laws contain an advance notice provision (the "Advance Notice By-law") for the purpose of providing shareholders, directors and management of the Company with a clear framework for nominating directors of the Company in connection with any annual or special meeting of shareholders.
The purpose of the Advance Notice By-law is to (i) ensure that all shareholders receive adequate notice of director nominations and sufficient time and information with respect to all nominees to make appropriate deliberations and register an informed vote; and (ii) facilitate an orderly and efficient process for annual or special meetings of shareholders of the Company. The Advance Notice By-law fixes the deadlines by which holders of record of Common Shares must submit director nominations to the Company prior to any annual or special meeting of shareholders and sets forth the information that a shareholder must include in a timely written notice to the Company for any director nominee to be eligible for election at such annual or special meeting of shareholders. In the case of an annual meeting of shareholders (including an annual and special meeting) a notice of nomination by a nominating shareholder must be made not less than thirty (30) nor more than sixty (60) days prior to the date of the meeting, provided, however, that in the event that the meeting is to be held on a date that is less than fifty (50) days after the date (the "Notice Date") on which the first public announcement of the date of the meeting was made, notice by a nominating shareholder must be made not later than the close of business on the tenth (10th) day following the Notice Date. In the case of a special meeting (which is not also an annual meeting) of shareholders called for the purpose of electing directors (whether or not also called for other purposes), a notice of nomination by a nominating shareholder must be made not later than the close of business on the fifteenth (15th) day following the day on which the first public announcement of the date of the meeting was made.
The by-laws of the Company are available under the Company's profiles on SEDAR at www.sedar.com and EDGAR at www.sec.gov.
Indemnification and Insurance
The Company has implemented a director and officer insurance program and has entered into indemnification agreements with each of its directors and executive officers. The indemnification agreements generally require that the Company indemnify and hold the indemnitees harmless to the greatest extent permitted by law for liabilities arising out of the indemnitees’ service to the Company as directors and executive officers, provided that the indemnitees acted honestly and in good faith and in a manner the indemnitees reasonably believed to be in or not opposed to the Company’s best interests and, with respect to criminal and administrative actions or proceedings that are enforced by monetary
60
penalty, the indemnitees had no reasonable grounds to believe that his or her conduct was unlawful. The indemnification agreements also provide for the advancement of defence expenses to the indemnitees by the Company.
61
ADDITIONAL INFORMATION
Indebtedness of Directors and Executive Officers
None of the directors or proposed director nominees, executive officers, employees, former directors, former executive officers or former employees of the Company or any of its subsidiaries, and none of their associates, is or has, at any time since the beginning of the Company’s most recently completed fiscal year, been indebted to the Company or any of its subsidiaries. Additionally, the Company or any of its subsidiaries has not provided any guarantee, support agreement, letter of credit or other similar agreement or understanding in respect of any indebtedness of any such person to any person or entity, except for routine indebtedness as defined under applicable securities legislation.
Interest of Certain Persons and Companies in Matters to be Acted Upon
No director, proposed director nominee or officer of the Company, or any person who has been a director or officer of the Company at any time since the beginning of the Company’s last fiscal year, nor any associate or affiliate of any such person, has any material interest, direct or indirect, by way of beneficial ownership of securities or otherwise, in any matter to be acted upon at the Meeting, other than as set forth herein.
Interest of Informed Persons in Material Transactions
Other than as set out below or as described elsewhere in this Circular, management of the Company is not aware of any material interest, direct or indirect, of any informed person of the Company, any proposed director nominee, or any associate or affiliate of any informed person or proposed director nominee, in any transaction since the commencement of the Company’s most recently completed fiscal year or in any proposed transaction that has materially affected or would materially affect the Company or any of its subsidiaries.
PIPE Financing
Immediately prior to closing of the business and plan of reorganization (the "Business Combination") between a wholly-owned subsidiary of Lion and Northern Genesis Acquisition Corp. which was completed on May 6, 2021, Lion completed a private placement (the "PIPE Financing") pursuant to which a number of investors agreed to purchase, and Lion agreed to sell to such investors, an aggregate of 20,040,200 Common Shares for an aggregate purchase price of $200,402,000. In connection with the PIPE Financing, Lion entered into subscription agreement with Power Energy pursuant to which Power Energy purchased, subject to the terms and conditions contained therein, a total of 1,662,500 Common Shares for a total purchase price of $16,625,000. In addition, Lion entered into subscription agreements with certain of Lion’s shareholders, directors and/or officers pursuant to which such subscribers purchased, directly or indirectly, subject to the terms and conditions contained therein, Common Shares at a purchase price of $10.00 per share. Such Common Shares were acquired upon the same terms and conditions as the Common Shares acquired by all other subscribers in the PIPE Financing.
Registration Rights Agreement
Effective as of closing of the Business Combination, Lion entered into a registration rights agreement (the "Registration Rights Agreement") pursuant to which, subject to the terms and conditions contained therein, each of Power Energy, 9368-2672 and Amazon.com NV Investment Holdings LLC (the "Warrantholder") were granted certain rights with respect to the registration or qualification by prospectus in the United States and/or Canada of the sale of the Common Shares held by them. A summary of the terms of the Registration Rights Agreement is described in the Section entitled “Material Contracts” of the Company’s annual report on Form 20-F dated March 29, 2022 and which is available under the Company's profiles on SEDAR at www.sedar.com and EDGAR at www.sec.gov.
62
Available Information
The Company is required under applicable Canadian and U.S. securities laws to file various documents, including financial statements. Financial information is provided in the audited annual consolidated financial statements of the Company for Fiscal 2021, together with the notes thereto, the Report of Independent Registered Public Accounting Firm thereon and the related management’s discussion and analysis. Copies of these documents and additional information concerning the Company can be found under the Company's profiles on SEDAR at www.sedar.com and EDGAR at www.sec.gov. Copies of the Company’s audited annual consolidated financial statements and management’s discussion and analysis can also be obtained upon request made to the Vice President, Investor Relations and Sustainable Development of the Company, Ms. Isabelle Adjahi, at the head office: 921, chemin de la Rivière du Nord, Saint-Jerome (Québec), Canada, J7Y 5G2.
Shareholder Proposals for Next Annual Meeting of Shareholders
The Company received no shareholder proposal for inclusion in this Circular. The Company will include proposals from shareholders that comply with applicable laws in next year’s management proxy circular for its next annual shareholder meeting to be held in respect of the fiscal year ending on December 31, 2022. Shareholder proposals must be received prior to the close of business on December 30, 2023 and be sent to the Chief Legal Officer and Corporate Secretary of the Company, Mr. François Duquette, at the head office: 921, chemin de la Rivière du Nord, Saint-Jerome (Québec), Canada, J7Y 5G2.
Approval by Directors
The Board of Directors of the Company approved the contents of this Circular and authorized it to be made available to and/or sent, as applicable, to each shareholder of the Company who is eligible to receive notice of, and vote his or her Common Shares at, the Meeting, as well as to the Company's independent auditor and each of its directors.
Dated at Saint-Jerome, this 29th day of March, 2022.
François Duquette (Signed)
Chief Legal Officer and Corporate Secretary
63
SCHEDULE A
| | |
THE LION ELECTRIC COMPANY MANDATE OF THE BOARD OF DIRECTORS |
Introduction
The Board of Directors (the "Board") of The Lion Electric Company (the "Company") is responsible for exercising all the powers necessary to manage, or supervise the management of, the business and affairs of the Company. Its members (the "Directors") are elected by the shareholders of the Company. The purpose of this mandate of the Board (the "Mandate") is to describe the primary duties and responsibilities of the Board, as well as some of the policies and procedures that apply to the Board in discharging its duties and responsibilities.
Certain aspects of the composition and organization of the Board are prescribed and/or governed by the Business Corporations Act (Québec) and the constating documents of the Company, and applicable agreements, including the nomination rights agreement dated May 6, 2021 (the "Nomination Rights Agreement").
Duties and Responsibilities of the Board
Pursuant to applicable laws, in exercising their powers and discharging their duties, Directors are duty-bound toward the Company to act with prudence and diligence, honesty and loyalty and in the interest of the Company. In furtherance of its responsibility and purpose, the primary duties and responsibilities of the Board include:
Corporate Strategy and Budgets
•ensuring a strategic planning process is in place and reviewing, on at least an annual basis, the principal business objectives for the Company, which consider, among other things, the opportunities and risks of the business;
•approving the Company’s annual operating and capital budgets;
•monitoring the Company’s success in implementing the strategy and achieving its goals;
Risk Management
•identifying, in conjunction with management, the principal risks applicable to the Company, and overseeing management’s implementation of appropriate systems to seek to effectively monitor, manage and mitigate the impact of such risks, provided that pursuant to its duty to oversee the implementation of effective risk management policies and procedures, the Board may delegate to applicable Board committees the responsibility for assessing and implementing appropriate policies and procedures to address specified risks, including delegation of risk management to committees of the Board;
•ensuring adequate disclosure of how the Board oversees risk;
•overseeing the Company’s corporate governance policies and practices and their disclosure in public disclosure documents;
•monitoring the size and composition of the Board, determining the appropriate qualifications and criteria for the selection of Board members and overseeing the nomination process for new Directors, in each case subject to the terms of the Nomination Rights Agreement or any other agreement among shareholders of the Company and the Company, as applicable;
•developing a succession plan for the Directors;
•developing position descriptions for the chair of the Board and the chair of each committee of the Board;
•developing a process for the assessment of the effectiveness and contribution of the Board, the committees of the Board and the individual Directors;
•ensuring that all new Directors receive a comprehensive orientation with respect to the role of the Board and its committees and nature and operations of the Company’s
64
business as well as the contribution individual Directors are expected to make (including, in particular, the commitment of time and resources that the Company expects from its Directors);
•providing continuing education opportunities for all Directors, so that individuals may maintain or enhance their skills and abilities as Directors, as well as ensuring their knowledge and understanding of the Company’s business remains current;
•adopting and monitoring compliance with key corporate policies and procedures designed to ensure that the Company, its Directors, officers and employees comply with all applicable laws, rules and regulations and conduct their business ethically and with honesty and integrity;
•monitoring the implementation of procedures and initiatives relating to corporate social and environmental responsibilities, and health and safety rules and regulations in the organization;
Chief Executive Officer, Officers and Compensation and Benefits
•appointing the Chief Executive Officer (the "CEO") and developing the corporate goals and objectives that the CEO is responsible for meeting, and reviewing the performance of the CEO against such goals and objectives;
•developing, together with the CEO, a position description for the CEO, which includes delineation of management’s responsibilities;
•approving the appointment of the senior officers of the Company and the assessment of each senior officer’s contribution to the achievement of the Company’s strategy;
•evaluating the performance of the CEO and other executive officers against the objectives established by the Board;
•approving the compensation of the senior executives of the Company upon recommendation of the Human Resources and Compensation Committee;
•providing stewardship in terms of succession planning, and ensuring that the Company has effective programs in place for leadership development and the appointment, training and supervision of management;
•establishing the goals and objectives relevant to the compensation philosophy, overseeing executive compensation and evaluating risks associated with executive compensation and incentive plans;
•approving the Company’s compensation policy for Directors;
•taking steps to satisfy itself as to the integrity of the senior executives of the Company and that the senior executives create a culture of integrity throughout the organization;
Financial Reporting and Transactions
•approving the Company’s financial statements and other financial information filed with applicable securities regulators;
•appointing, subject to approval of shareholders, and removing of the Company’s auditor;
•monitoring internal controls and management information systems, and reviewing related procedures and reporting;
•reviewing, approving and overseeing the Company’s disclosure controls and procedures;
•serving as an advisor to management and reviewing and approving major business decisions including material transactions outside the ordinary course of business and those matters which the Board is required to approve under the Company’s governing statute, including the payment of dividends, issuances, purchases and redemptions of securities, and acquisitions and dispositions of material capital assets;
Legal Requirements and Communications
•overseeing compliance with disclosure requirements applicable to the Company, including disclosure of material information in accordance with applicable securities laws and stock exchange rules;
65
•adopting a disclosure policy for the Company and overseeing communications with shareholders, other stakeholders, analysts and the public, including the adoption of measures for receiving feedback from stakeholders and reporting to shareholders as necessary;
•overseeing the adequacy of the Company’s processes to ensure compliance by the Company with applicable legal and regulatory requirements;
Review of Mandate and Delegation
The Board may, from time to time, permit departures from the terms of this Mandate, either prospectively or retrospectively. This Mandate is not intended to give rise to civil liability on the part of the Company or its Directors or officers to shareholders, securityholders, customers, suppliers, competitors, employees or other persons, or to any other liability whatsoever on their part. The Board may review and recommend changes to the Mandate from time to time and the Nominating and Corporate Governance Committee may periodically review and assess the adequacy of this Mandate and recommend any proposed changes to the Board for consideration.
The Board shall delegate to the CEO, other officers and management personnel appropriate powers to manage the business and affairs of the Company. The Board may delegate, subject to applicable laws, certain matters it is responsible for to committees of the Board, presently consisting of the Audit Committee, the Nominating and Corporate Governance Committee and the Human Resources and Compensation Committee.
66